Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Reproductive Biology and Endocrinology : RB&E|October 30, 2012
Roles of prostaglandin F2alpha and hydrogen peroxide in the regulation of Copper/Zinc superoxide dismutase in bovine corpus luteum and luteal endothelial cellsHai V Vu, Seunghyung Lee, Tomas J Acosta, et al.Journal of Immunological Methods|October 16, 2002
Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patientsHironori Abe, Motomu Kuroki, Takayuki Imakiire, et al.Plos One|March 4, 2014
Lymphatic involvement in the disappearance of steroidogenic cells from the corpus luteum during luteolysisHironori Abe, Mohamad Omar Al-zi'abi, Fumio Sekizawa, et al.Nature Communications|November 28, 2022
Active DNA damage response signaling initiates and maintains meiotic sex chromosome inactivationHironori Abe, Yu-Han Yeh, Yasuhisa Munakata, et al.Anticancer Research|August 15, 2002
Targeting of interleukin-2 to human MK-1-expressing carcinoma by fusion with a single-chain Fv of anti-MK-1 antibodyHisanobu Matsumoto, Shaoxi Liao, Fumiko Arakawa, et al.Matrix Biology : Journal of the International Society for Matrix Biology|September 13, 2002
Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cellsYasushi Yamauchi, Motomu Kuroki, Takayuki Imakiire, et al.Human Molecular Genetics|January 24, 2018
CHEK1 coordinates DNA damage signaling and meiotic progression in the male germline of miceHironori Abe, Kris G Alavattam, Yasuko Kato, et al.Biochemical and Biophysical Research Communications|February 1, 2002
Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937Yasushi Yamauchi, Motomu Kuroki, Takayuki Imakiire, et al.Current Biology : CB|January 7, 2020
The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse SpermatogenesisHironori Abe, Kris G Alavattam, Yueh-Chiang Hu, et al.Anticancer Research|May 17, 2002
T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibodyAruto Ueno, Fumiko Arakawa, Hironori Abe, et al.Pageof 5